Oxidative stress, defective proteostasis and immunometabolic complications in critically ill patients

被引:1
|
作者
Galli, Francesco [1 ]
Bartolini, Desiree [1 ]
Ronco, Claudio [2 ]
机构
[1] Univ Perugia, Dept Pharmaceut Sci, Univ Pole Via Giochetto,Bldg B,2nd floor, I-06123 Perugia, Italy
[2] Univ Padua, San Bortolo Hosp Vicenza, Int Renal Res Inst Vicenza, Dept Med, Vicenza, Italy
关键词
critically ill patients; immune dysfunction; immunoresponse; inflammation; intensive care; multiorgan failure; oxidative stress; protein damage; proteostasis; proteostasis acute kidney injury; ACUTE LUNG INJURY; VITAMIN-E; AMINO-ACID; PROTEIN MODIFICATION; LIPID-PEROXIDATION; HYDROGEN-PEROXIDE; OXIDANT STRESS; TRACE-ELEMENTS; CELL-DEATH; SEPSIS;
D O I
10.1111/eci.14229
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Oxidative stress (OS) develops in critically ill patients as a metabolic consequence of the immunoinflammatory and degenerative processes of the tissues. These induce increased and/or dysregulated fluxes of reactive species enhancing their pro-oxidant activity and toxicity. At the same time, OS sustains its own inflammatory and immunometabolic pathogenesis, leading to a pervasive and vitious cycle of events that contribute to defective immunity, organ dysfunction and poor prognosis. Protein damage is a key player of these OS effects; it generates increased levels of protein oxidation products and misfolded proteins in both the cellular and extracellular environment, and contributes to forms DAMPs and other proteinaceous material to be removed by endocytosis and proteostasis processes of different cell types, as endothelial cells, tissue resident monocytes-macrophages and peripheral immune cells. An excess of OS and protein damage in critical illness can overwhelm such cellular processes ultimately interfering with systemic proteostasis, and consequently with innate immunity and cell death pathways of the tissues thus sustaining organ dysfunction mechanisms. Extracorporeal therapies based on biocompatible/bioactive membranes and new adsorption techniques may hold some potential in reducing the impact of OS on the defective proteostasis of patients with critical illness. These can help neutralizing reactive and toxic species, also removing solutes in a wide spectrum of molecular weights thus improving proteostasis and its immunometabolic corelates. Pharmacological therapy is also moving steps forward which could help to enhance the efficacy of extracorporeal treatments. This narrative review article explores the aspects behind the origin and pathogenic role of OS in intensive care and critically ill patients, with a focus on protein damage as a cause of impaired systemic proteostasis and immune dysfunction in critical illness. image
引用
收藏
页数:21
相关论文
共 50 条
  • [41] Procalcitonin in the recognition of complications in critically ill surgical patients
    Meyer, Zainna C.
    Schreinemakers, Jennifer M. J.
    Mulder, Paul G. H.
    Schrauwen, Lianne
    de Waal, Ruud A. L.
    Ermens, Antonius A. M.
    van der Laan, Lijckle
    JOURNAL OF SURGICAL RESEARCH, 2014, 187 (02) : 553 - 558
  • [42] Bleeding complications in critically ill patients with liver cirrhosis
    Cho, Jaeyoung
    Choi, Sun Mi
    Yu, Su Jong
    Park, Young Sik
    Lee, Chang-Hoon
    Lee, Sang-Min
    Yim, Jae-Joon
    Yoo, Chul-Gyu
    Kim, Young Whan
    Han, Sung Koo
    Lee, Jinwoo
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2016, 31 (02): : 288 - 295
  • [43] Hospital-acquired complications in critically ill patients
    Duke, Graeme J.
    Shann, Frank
    Knott, Cameron, I
    Oberender, Felix
    Pilcher, David, V
    Roodenburg, Owen
    Santamaria, John D.
    CRITICAL CARE AND RESUSCITATION, 2021, 23 (03) : 285 - 291
  • [44] AN OVERVIEW ON COMPLICATIONS OF PARENTERAL THERAPY IN CRITICALLY ILL PATIENTS
    Alharbi, Mohammed Falah
    Asiri, Alaa Mohammed
    Aldosari, Hamad Khalid
    Alnashi, Khalid Saad
    Mursi, Mahmoud Ayman
    Al Shuqayfah, Nawaf Ibrahim
    Almulhim, Faisal Abdulaziz
    Alkhalaf, Khalaf Mohammed
    Almazyadi, Hussain Shaker H.
    PHARMACOPHORE, 2021, 12 (02): : 93 - 95
  • [45] Complications of femoral venous catheterization in critically ill patients
    Al-Jawder, SE
    Hameed, AA
    SAUDI MEDICAL JOURNAL, 2004, 25 (02) : 240 - 241
  • [46] Complications during the intrahospital transport in critically ill patients
    Damm, C
    Vandelet, P
    Petit, J
    Richard, JC
    Veber, B
    Bonmarchand, G
    Dureuil, B
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 2005, 24 (01): : 24 - 30
  • [47] Bleeding and thrombotic complications in critically ill patients with cancer
    DeSancho, MT
    Rand, JH
    CRITICAL CARE CLINICS, 2001, 17 (03) : 599 - +
  • [48] GASTROINTESTINAL COMPLICATIONS IN CRITICALLY ILL PATIENTS - THE INTENSIVISTS OVERVIEW
    GOTTLIEB, JE
    MENASHE, PI
    CRUZ, E
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1986, 81 (04): : 227 - 238
  • [49] Intrahospital transport of critically ill patients: Complications and difficulties
    Lovell, MA
    Mudaliar, MY
    Klineberg, PL
    ANAESTHESIA AND INTENSIVE CARE, 2001, 29 (04) : 400 - 405
  • [50] Hospital-acquired complications in critically ill patients
    Bellomo, Rinaldo
    CRITICAL CARE AND RESUSCITATION, 2021, 23 (04) : 357 - 358